Zhangzhou Pientzehuang Pharmaceutical | 600436 - Ebitda

Aktienkurs
143.55
Täglich Wechseln
4.23 3.04%
Monatlich
-5.00%
Jährlich
-30.09%
Q2 Prognose
138.99




Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Avita Medical AUD -9.69M 12.21M 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
Jiangsu Hengrui CNY 2.3B 678.46M 2025-12
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Moderna USD -790M 582M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Sh Fosun Pharma CNY 1.57B 128.23M 2025-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Viatris USD 1B 151.5M 2025-12
WuXi AppTec CNY 8.95B 3.24B 2025-12
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06